KERRERA TINDAL: Open Payments
NPI 1538779178 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 54 payments from 11 companies in 2025. Trend: 2023 $192 · 2024 $187 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 10 | $220 |
| AstraZeneca Pharmaceuticals LP | 7 | $191 |
| Travere Therapeutics, Inc. | 8 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $152 |
| SCPHARMACEUTICALS INC. | 4 | $94 |
| Ardelyx, Inc. | 3 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Recor Medical Inc | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Aurinia Pharma U.S., Inc. | 2 | $43 |
Products named: TARPEYO, FARXIGA, Kerendia, FUROSCIX, IBSRELA, JYNARQUE, Paradise Ultrasound Renal Denervation System, JARDIANCE.
Industry payments across SC — which companies pay providers there.
